CompoAtlas

Canneberge Pépins de Courge

Food supplement declared in France, declaration No 2019-8-375

Canneberge Pépins de Courge is a food supplement declared in France. Status: retrait du marché annoncé pour le 17 October 2027. 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
New Stefal Holding
Status
Retrait du marché annoncé pour le 17 October 2027
Form
Flacon
Daily dose
15 ml
Directions for use
Prendre 15 ml par jour le matin à l'aide du bouchon doseur, purs ou dilués dans un 1/2 verre d'eau.
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Maladie rénale
Objectives stated by the manufacturer (these are not authorised claims)
Système urinaire

Declaration 214416, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Cucurbita pepo L.GraineExtrait sec hydroalcoolique60 mg
Santalum album L.BoisPoudre (de plantes séchées ou broyées)60 mg
Vaccinium macrocarpon AitonFruitPoudre (de plantes séchées ou broyées)14 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Béta-carotèneBêta-carotènepas de limite (données insuffisantes)aucune dose fixée
Acétate de DL-alpha-tocophéryleVitamine E300 mg30 mg
Gluconate de zincZinc25 mg15 mg

Additives

E330, E202, E211

Other ingredients

Eau potable, fructose, jus d'orange

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

L'emploi chez les fumeurs personnes souffrant d'une maladie rénale est déconseillé. Ne convient pas aux femmes enceintes ou qui allaitent.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Enter to analyse, Shift+Enter for a new line